737PMulticenter phase II trial of axitinib monotherapy for advanced biliary tract cancer refractory to gemcitabine-based chemotherapy
Okano, N, Ueno, M, Morizane, C, Yamanaka, T, Ojima, H, Ozaka, M, Sasaki, M, Takahara, N, Kobayashi, S, Morimoto, M, Hosoi, H, Nakai, Y, Ikeda, M, Maeno, S, Nagashima, F, Okusaka, T, Furuse, JVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.064
Date:
October, 2019
File:
PDF, 74 KB
2019